文献速递甲状腺疾病

优化细针穿刺活检降钙素测定在检测甲状腺髓样癌中的诊断准确性

Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
PubMed 文献 · Thyroid · 2024-01-12

本研究为嵌套于前瞻性多中心队列的病例对照研究,纳入50例甲状腺髓样癌(MTC)患者和105例对照,评估细针穿刺洗脱液降钙素(FNA-Ctn)的诊断准确性。FNA-Ctn的AUROC为0.99,阈值≥220 pg/mL时诊断MTC的敏感性为100%、特异性为98%。在多发结节性甲状腺肿患者中,FNA-Ctn可能有助于MTC的定位。

要点

  • FNA-Ctn诊断MTC的AUROC为0.99(95%CI 0.98-1.0)。
  • FNA-Ctn阈值≥220 pg/mL时,诊断MTC敏感性100%、特异性98%。
  • 在多发结节性甲状腺肿中,FNA-Ctn可能有助于MTC定位。

核心结论

  • 采用电化学发光免疫分析法(ECLIA)测定FNA-Ctn对MTC诊断具有足够的诊断准确性,并可能在考虑肺叶切除术时对多发结节性甲状腺肿的定位有临床用处。

研究设计与样本

  • 本研究为嵌套于前瞻性多中心队列的病例对照研究,队列纳入1272例结节性或多发结节性甲状腺肿、血清降钙素正常或升高且有甲状腺切除术指征的患者。
  • 从该嵌套队列中识别出50例MTC病例和105例对照(非髓样病理),对照按1:2比例随机累积抽样。
  • 共评估286个甲状腺结节(63个MTC结节和223个非MTC结节)。

主要发现

  • 病例组血清降钙素中位值为525 pg/mL(IQR 162.5-1.200),显著高于对照组1.6 pg/mL(IQR 0.5-5.6),p < 0.001。
  • MTC结节FNA-Ctn中位值为3.100 pg/mL(IQR 450-45,200),显著高于非MTC结节0.5 pg/mL(IQR 0.5-0.5),p < 0.0001。
  • 在11例合并多发结节性甲状腺肿的MTC患者中,位于同一腺叶的非髓样结节的FNA-Ctn值显著更高,p = 0.0002。
  • FNA-Ctn的AUROC为0.99(95%CI 0.98-1.0),阈值≥220 pg/mL诊断MTC的敏感性为100%、特异性为98%。

关键数值与推荐

  • FNA-Ctn阈值≥220 pg/mL诊断MTC的敏感性为100%、特异性为98%。

临床怎么用

  • 作者认为,采用ECLIA测定FNA-Ctn对MTC诊断具有足够的诊断准确性,并可能在考虑肺叶切除术时对多发结节性甲状腺肿的定位有临床用处。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The optimal cutoff value of calcitonin (Ctn) levels measured using an electrochemiluminescence immunoassay (ECLIA) obtained from the washout fluid of fine needle aspiration (FNA-Ctn) for the diagnosis of medullary thyroid carcinoma (MTC) is currently not established. We evaluated the diagnostic accuracy and clinical utility of FNA-Ctn for the diagnosis and location of MTC in patients with nodular or multinodular goiters. Methods: This was a case-control study nested on a prospective multicenter cohort of patients with nodular or multinodular goiter, normal or elevated serum Ctn, and thyroidectomy indications. Ctn and FNA-Ctn were measured using ECLIA methodology before surgery. From this nested cohort, MTC cases and controls (non-medullary pathology) were identified from the final pathological analysis. Cumulative incidence sampling of controls was randomly performed at a ratio of 1:2. Sensitivity, specificity, and area under the receiver operator curve (AUROC) were calculated for patients and the total number of thyroid nodules. Results: From 1272 patients included in the prospective cohort, 50 MTC cases and 105 controls were included. In this study, 286 thyroid nodules were evaluated (63 MTC and 223 non-MTCs). The median serum Ctn value was significantly higher in cases (525 pg/mL [interquartile range (IQR), 162.5-1.200]) than in controls (1.6 pg/mL [IQR, 0.5-5.6]; p < 0.001). The median FNA-Ctn value was significantly higher in MTC nodules (3.100 pg/mL [IQR, 450-45,200]) than in non-MTC nodules (0.5 pg/mL [IQR, 0.5-0.5]; p < 0.0001). In 11 MTC patients with multinodular goiter, the FNA-Ctn value was significantly higher in non-medullary nodules located in the same lobe where an MTC nodule was diagnosed (p = 0.0002). Overall, the FNA-Ctn AUROC was 0.99 [95% confidence interval, 0.98-1.0], and a threshold of ≥220 pg/mL showed 100% sensitivity and 98% specificity for MTC diagnosis. Conclusions: The use of FNA-Ctn measured by ECLIA showed adequate diagnostic accuracy for MTC diagnosis. Moreover, it may be clinically useful for localization in multinodular goiter when lobectomy is considered. Clinical Trial Registration: Clinicaltrials.gov NCT06067594.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Cavallo AC, Pitoia F, Roberti J, et al. Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma. Thyroid. 2024. PMID: 38047535. doi:10.1089/thy.2023.0313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。